793 results found
Our current legislative basis is the National Health and Medical Research Council Act 1992 (NHMRC Act). We are responsible to the Commonwealth Minister for Health.
Tuberculosis (TB) is an infection that can affect almost any part of the body, but it mostly affects the lungs. It is not common in Australia but is very common in other areas of the world.People with TB may have symptoms such as fever, tiredness, sweating (especially at night), weight loss and a persistent cough that does not go away with normal treatment. The cough may produce phlegm and sometimes blood. A chest X-ray can help diagnose TB.
Typhoid is a serious disease that needs immediate treatment. Symptoms usually develop 1 day to 2 weeks after exposure, and sometimes up to 2 months after. Symptoms include fever, headache, tiredness and stomach pain.Tyhoid is caused by infection with the bacteria Salmonella Typhi. Paratyphoid fever is a similar disease caused by a different but related bacteria, Salmonella Paratyphi. Paratyphoid infections are usually less severe than typhoid infections.Typhoid and paratyphoid are not common in Australia, but people can catch them if they travel to places such as India, Africa, Asia, South and Central America and the Middle East.
NHMRC promotes the highest quality in the research that it funds.
MatCH is one of five cohort studies embedded in the Australian Longitudinal Study on Women’s Health (ALSWH— also known as Women's Health Australia). MatCH is increasing our understanding of the intergenerational determinants of child health and development in Australia, and MatCH data are providing an unprecedented opportunity to investigate preconception and life course determinants of child health outcomes. ALSWH is a national research resource providing an evidence base to assist policy makers to develop and evaluate policy and practice in service delivery areas affecting women.
The Clinical Practice Guidelines for the management of overweight and obesity in adults, adolescents and children in Australia is intended for use by clinicians including general practitioners.
This Clinical Practice Guideline for the management of Borderline Personality Disorder will assist health professionals to diagnose, treat and manage BPD in adolescents and adults.